Purchase Order 75N95023P00625
- Not listed
- Revvity Health Sciences, Inc., a division of Revvity Inc. Medical Imaging, LLC, has been awarded a $14,616.86 firm fixed-price purchase order by the National Institutes of Health's National Heart, Lung and Blood Institute to provide a Cellometer Auto 2000 instrument. This equipment will allow the recipient laboratory to continue ongoing scientific projects and clinical protocols, as requested in Solicitation 23-016802. As the prime contractor, Revvity Health Sciences will furnish the specified...
- The Department of Health and Human Services (HHS), National Institutes of Health (NIH), National Human Genome Research Institute (NHGRI) awarded a $167,700 firm fixed-price purchase order to Revvity Health Sciences, Inc. to provide a Celigo Cytometer Imaging System. This system will be used for research at the Childhood Complex Disease Genomics Section. The Celigo platform enables direct, real-time analysis of cells in various vessel types without disturbing their natural state. This purchase...
- Revvity Health Sciences, Inc., a division of Revvity Inc. Medical Imaging, LLC, has been awarded a $14,940.06 firm fixed-price purchase order by the Department of Health and Human Services' National Institutes of Health's National Institute of Allergy and Infectious Diseases to deliver a CELLOMETER AUTO 2000 BUNDLE (AMBIS #2185560). Performance will occur in Shelton, Connecticut over a six-month period concluding in March 2024. No subcontractors or set-aside designations were indicated. This...
- This federal contract award to Revvity Health Sciences, Inc. is for the provision of a CELLOMETER medical imaging product to the National Eye Institute, a civilian agency under the National Institutes of Health (NIH). The fixed-price purchase order, valued at $17,806.96, has an ultimate completion date of October 25, 2024. The contract does not have a set-aside designation. Revvity Health Sciences is a for-profit manufacturer of medical devices and equipment that has a history of providing...
- Revvity Health Sciences, Inc. has been awarded a firm fixed price purchase order from the Department of Health and Human Services' National Institutes of Health's National Institute of Neurological Disorders and Stroke for a cell counter. With a potential value of $12,985, this unrestricted award has a completion date of June 30, 2024. To be performed in Hopkinton, Massachusetts, the purchase order is for the delivery of a cell counter to support the National Institute of Neurological...
- This is a $14,862.05 firm fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. Department of Health and Human Services, to Revvity Health Sciences, Inc. The contract is for the delivery of a CELLOMETER AUTO 200 BUNDLE. Revvity Health Sciences, Inc. is a subsidiary of Revvity Inc., a for-profit corporation that provides medical imaging products and services to federal agencies. The contract does not have a...
- The Department of Health and Human Services' National Institutes of Health awarded a firm fixed-price purchase order worth $176,376.98 to Revvity Health Sciences, Inc. for a Cellaca MX High Throughput-High Speed Cell Counting System and accessories. The contract is to support the National Institute of Allergy and Infectious Diseases (NIAID) and has a period of performance ending on July 30, 2023. There was no set-aside used for this acquisition, which was competed under Simplified Acquisition...
- Revvity Health Sciences, Inc., a subsidiary of Revvity Inc. Medical Imaging, LLC, has been awarded a firm fixed price purchase order valued at one hundred forty thousand, four hundred forty-three dollars and twenty-six cents ($140,443.26) by the National Institutes of Health's National Institute of Child Health and Human Development. Under this contract, Revvity will provide one (1) Panoramic MIDI BF Plus FL Advanced imaging system and one (1) HistoQuant software license to support the NIH's...
- This is a firm fixed-price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases, a civilian agency within the U.S. Department of Health and Human Services, to Revvity Health Sciences, Inc. for the provision of a "CELLOMETER ASCEND BUNDLE" valued at $17,806.96. The contract has an ultimate completion date of September 10, 2025. Revvity Health Sciences, Inc. is a for-profit manufacturer that provides a variety of medical imaging products and...
- This firm-fixed-price purchase order was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. Department of Health and Human Services, to Revvity Health Sciences, Inc. on September 5, 2024. The $17,806.96 contract is for the delivery of a Cellometer Ascend Bundle laboratory instrument, with a period of performance through December 31, 2024. The award does not utilize a small business set-aside. Revvity Health Sciences is a for-profit...
Revvity Signals Software, Inc. Informatics Division, a subsidiary of Revvity Inc. Medical Imaging, LLC, has been awarded a $93,652 firm fixed price purchase order by the National Institutes of Health's National Center for Advancing Translational Sciences to provide a Celleca PLX Image Cytometer in support of the Stem Cell Translation Laboratory. The solicitation sought to advance stem cell technologies for clinical application, drug discovery, and regenerative medicine through the establishment of the SCTL. Key deliverables include provision of an instrument for routine maintenance and differentiation culture of induced pluripotent stem cells to measure cell viability and immunophenotypes, enabling collaboration opportunities for researchers. The purchase order aims to further the NIH's efforts in bringing induced pluripotent stem cell therapy closer to clinical use.
Name | Description | Solicitation Number | FederalAgency | Type | PostedDate |
|---|---|---|---|---|---|
Celleca PLX Image Cytometer | 75N95023Q00518 | Department of Health and Human Services National Institutes of Health National Institute on Drug Abuse | Pre-Solicitation 1/1 | 7/31/23, 5:10 PM |
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $93.7k | 8/23/23 |